Literature DB >> 33414760

Case Report: 18F-MK6240 Tau Positron Emission Tomography Pattern Resembling Chronic Traumatic Encephalopathy in a Retired Australian Rules Football Player.

Natasha Krishnadas1,2, Vincent Doré2,3, Fiona Lamb2, Colin Groot4, Paul McCrory5, Rodney Guzman2, Rachel Mulligan2, Kun Huang2, Meaghan O'Donnell6,7, Jennie Ponsford8, Malcolm Hopwood7, Victor L Villemagne2, Christopher C Rowe2,5.   

Abstract

Introduction: It remains unclear if tau imaging may assist diagnosis of chronic traumatic encephalopathy (CTE). Flortaucipir PET has shown superior frontal with medial temporal tau binding consistent with the provisional neuropathological criteria for mid-stage CTE in group-level analyses of retired symptomatic NFL players and in one individual with pathologically confirmed CTE. 18F-MK6240 is a new PET ligand that has high affinity for tau. We present the case of a 63-year-old cognitively impaired, former Australian rules football player with distinct superior frontal and medial temporal 18F-MK6240 binding and show it to be significantly different to the pattern seen in prodromal Alzheimer's disease (AD). Findings: The participant was recruited for a study of amyloid-β and tau several decades after traumatic brain injury. He had multiple concussions during his football career but no cognitive complaints at retirement. A thalamic stroke in his mid 50s left stable mild cognitive deficits but family members reported further short-term memory, behavioral, and personality decline preceding the study. Imaging showed extensive small vessel disease on MRI, a moderate burden of amyloid-β plaques, and 18F-MK6240 binding in bilateral superior frontal and medial temporal cortices. Voxel-wise analysis demonstrated that the frontally predominant pattern of the participant was significantly different to the posterior temporo-parietal predominant pattern of prodromal AD.
Conclusion: Although lacking neuropathological examination to distinguish CTE from a variant of AD, the clear demonstration of a CTE-like tau pattern in a single at-risk individual suggests further research on the potential of 18F-MK6240 PET for identifying CTE is warranted.
Copyright © 2020 Krishnadas, Doré, Lamb, Groot, McCrory, Guzman, Mulligan, Huang, O'Donnell, Ponsford, Hopwood, Villemagne and Rowe.

Entities:  

Keywords:  Alzheimer's Disease (AD); Chronic Traumatic Encephalopathy (CTE); Positron Emission Tomography (PET); case report; tau

Year:  2020        PMID: 33414760      PMCID: PMC7783156          DOI: 10.3389/fneur.2020.598980

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  25 in total

1.  Tau Positron-Emission Tomography in Former National Football League Players.

Authors:  Robert A Stern; Charles H Adler; Kewei Chen; Michael Navitsky; Ji Luo; David W Dodick; Michael L Alosco; Yorghos Tripodis; Dhruman D Goradia; Brett Martin; Diego Mastroeni; Nathan G Fritts; Johnny Jarnagin; Michael D Devous; Mark A Mintun; Michael J Pontecorvo; Martha E Shenton; Eric M Reiman
Journal:  N Engl J Med       Date:  2019-04-10       Impact factor: 91.245

Review 2.  Traumatic encephalopathy: review and provisional research diagnostic criteria.

Authors:  Jeff Victoroff
Journal:  NeuroRehabilitation       Date:  2013       Impact factor: 2.138

Review 3.  The neuropathology of sport.

Authors:  Ann C McKee; Daniel H Daneshvar; Victor E Alvarez; Thor D Stein
Journal:  Acta Neuropathol       Date:  2013-12-24       Impact factor: 17.088

4.  The spectrum of disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Robert A Stern; Christopher J Nowinski; Thor D Stein; Victor E Alvarez; Daniel H Daneshvar; Hyo-Soon Lee; Sydney M Wojtowicz; Garth Hall; Christine M Baugh; David O Riley; Caroline A Kubilus; Kerry A Cormier; Matthew A Jacobs; Brett R Martin; Carmela R Abraham; Tsuneya Ikezu; Robert Ross Reichard; Benjamin L Wolozin; Andrew E Budson; Lee E Goldstein; Neil W Kowall; Robert C Cantu
Journal:  Brain       Date:  2012-12-02       Impact factor: 13.501

5.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

6.  Clinical and neuropsychological profile of patients with dementia and chronic traumatic encephalopathy.

Authors:  Christian LoBue; Jeff Schaffert; C Munro Cullum; Matthew E Peters; Nyaz Didehbani; John Hart; Charles L White
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-04-24       Impact factor: 10.154

Review 7.  Clinical subtypes of chronic traumatic encephalopathy: literature review and proposed research diagnostic criteria for traumatic encephalopathy syndrome.

Authors:  Philip H Montenigro; Christine M Baugh; Daniel H Daneshvar; Jesse Mez; Andrew E Budson; Rhoda Au; Douglas I Katz; Robert C Cantu; Robert A Stern
Journal:  Alzheimers Res Ther       Date:  2014-09-24       Impact factor: 6.982

8.  Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue.

Authors:  Cinthya Aguero; Maeva Dhaynaut; Marc D Normandin; Ana C Amaral; Nicolas J Guehl; Ramesh Neelamegam; Marta Marquie; Keith A Johnson; Georges El Fakhri; Matthew P Frosch; Teresa Gomez-Isla
Journal:  Acta Neuropathol Commun       Date:  2019-03-11       Impact factor: 7.801

9.  Chronic traumatic encephalopathy in two former Australian National Rugby League players.

Authors:  Michael E Buckland; Joanne Sy; Istvan Szentmariay; Alexandra Kullen; Maggie Lee; Antony Harding; Glenda Halliday; Catherine M Suter
Journal:  Acta Neuropathol Commun       Date:  2019-06-27       Impact factor: 7.801

10.  The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy.

Authors:  Ann C McKee; Nigel J Cairns; Dennis W Dickson; Rebecca D Folkerth; C Dirk Keene; Irene Litvan; Daniel P Perl; Thor D Stein; Jean-Paul Vonsattel; William Stewart; Yorghos Tripodis; John F Crary; Kevin F Bieniek; Kristen Dams-O'Connor; Victor E Alvarez; Wayne A Gordon
Journal:  Acta Neuropathol       Date:  2015-12-14       Impact factor: 17.088

View more
  7 in total

1.  Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players.

Authors:  Michael L Alosco; Yi Su; Thor D Stein; Eric M Reiman; Ann C McKee; Robert A Stern; Hillary Protas; Jonathan D Cherry; Charles H Adler; Laura J Balcer; Charles Bernick; Surya Vamsi Pulukuri; Bobak Abdolmohammadi; Michael J Coleman; Joseph N Palmisano; Yorghos Tripodis; Jesse Mez; Gil D Rabinovici; Kenneth L Marek; Thomas G Beach; Keith A Johnson; Bertrand Russell Huber; Inga Koerte; Alexander P Lin; Sylvain Bouix; Jeffrey L Cummings; Martha E Shenton
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-24       Impact factor: 10.057

Review 2.  Neuroimaging Biomarkers of Chronic Traumatic Encephalopathy: Targets for the Academic Memory Disorders Clinic.

Authors:  Michael L Alosco; Julia Culhane; Jesse Mez
Journal:  Neurotherapeutics       Date:  2021-04-13       Impact factor: 7.620

Review 3.  Identifying degenerative effects of repetitive head trauma with neuroimaging: a clinically-oriented review.

Authors:  Breton M Asken; Gil D Rabinovici
Journal:  Acta Neuropathol Commun       Date:  2021-05-22       Impact factor: 7.801

4.  Characterization of neuroinflammatory positron emission tomography biomarkers in chronic traumatic encephalopathy.

Authors:  Cassis Varlow; Ashley C Knight; Paul McQuade; Neil Vasdev
Journal:  Brain Commun       Date:  2022-02-03

Review 5.  Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective.

Authors:  Maria Ricci; Andrea Cimini; Riccardo Camedda; Agostino Chiaravalloti; Orazio Schillaci
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

6.  A Case of Possible Chronic Traumatic Encephalopathy and Alzheimer's Disease in an Ex-Football Player.

Authors:  Arman Fesharaki-Zadeh
Journal:  Neurologist       Date:  2022-09-01       Impact factor: 1.524

7.  Chronic Traumatic Encephalopathy as a Preventable Environmental Disease.

Authors:  Michael E Buckland; Andrew J Affleck; Alan J Pearce; Catherine M Suter
Journal:  Front Neurol       Date:  2022-06-13       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.